KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $5.6 million.

  • Medpace Holdings' Share-based Compensation fell 456.78% to $5.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $34.8 million, marking a year-over-year increase of 3634.08%. This contributed to the annual value of $34.8 million for FY2025, which is 3634.08% up from last year.
  • Per Medpace Holdings' latest filing, its Share-based Compensation stood at $5.6 million for Q4 2025, which was down 456.78% from $6.3 million recorded in Q3 2025.
  • Medpace Holdings' Share-based Compensation's 5-year high stood at $16.9 million during Q1 2025, with a 5-year trough of $2.9 million in Q1 2021.
  • Its 5-year average for Share-based Compensation is $5.8 million, with a median of $5.3 million in 2023.
  • In the last 5 years, Medpace Holdings' Share-based Compensation plummeted by 4727.27% in 2021 and then soared by 29192.58% in 2025.
  • Medpace Holdings' Share-based Compensation (Quarter) stood at $4.0 million in 2021, then skyrocketed by 40.49% to $5.6 million in 2022, then decreased by 7.65% to $5.2 million in 2023, then increased by 14.02% to $5.9 million in 2024, then fell by 4.57% to $5.6 million in 2025.
  • Its Share-based Compensation was $5.6 million in Q4 2025, compared to $6.3 million in Q3 2025 and $6.0 million in Q2 2025.